Literature DB >> 14629649

Increased macrophage inflammatory protein-1alpha and -1beta in BAL fluid of bronchiolitis obliterans organizing pneumonia.

Toru Asano1, Fumitaka Ogushi, Kenji Tani, Hiroyuki Tamiya, Yasuhiko Nishioka, Saburo Sone.   

Abstract

OBJECTIVE: CC chemokines are mainly chemotactic for monocytes and lymphocytes. The aim of this study was to evaluate the involvement of the CC chemokines, macrophage inflammatory protein (MIP)-1alpha and MIP-1beta, in the pathogenesis of bronchiolitis obliterans organizing pneumonia (BOOP).
METHODOLOGY: The concentrations of MIP-1alpha and MIP-1beta in BAL fluid (BALF) obtained from patients with BOOP (n = 13) and control patients (CP, n= 18) were measured by enzyme-linked immunosorbent assay.
RESULTS: MIP-1alpha in BALF was significantly higher in patients with BOOP (mean +/- SD; 123.8 +/- 98.0 pg/mL) than in CP (62.5 +/- 46.1 pg/mL). Significantly higher MIP-1beta was also detected in patients with BOOP (51.6 +/- 72.5 pg/mL) than in CP (6.4 +/- 3.7 pg/mL). The concentration of MIP-1alpha significantly correlated with the percentage of lymphocytes in BALF, and the concentration of MIP-1beta significantly correlated with the numbers of lymphocytes, neutrophils and eosinophils in BALF. Both MIP-1alpha and MIP-1beta in BALF were decreased after corticosteroid therapy and this was accompanied by decreased lymphocytes in BALF.
CONCLUSION: This study suggests that MIP-1alpha and MIP-1beta may play important roles in the recruitment of immuno-inflammatory cells into the lungs, and may contribute to the pathogenesis of BOOP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629649     DOI: 10.1046/j.1440-1843.2003.00496.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  1 in total

1.  Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study.

Authors:  Elżbieta Radzikowska; Elżbieta Wiatr; Renata Langfort; Iwona Bestry; Agnieszka Skoczylas; Ewa Szczepulska-Wójcik; Dariusz Gawryluk; Piotr Rudziński; Joanna Chorostowska-Wynimko; Kazimierz Roszkowski-Śliż
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.